Subtopic Deep Dive
Hepcidin-Ferroportin Axis
Research Guide
What is Hepcidin-Ferroportin Axis?
The Hepcidin-Ferroportin Axis is the master regulatory pathway of systemic iron homeostasis where liver-derived hepcidin binds ferroportin to induce its internalization and degradation, thereby controlling iron export from enterocytes, macrophages, and hepatocytes.
Hepcidin acts as a peptide hormone responding to iron levels and inflammation, while ferroportin serves as the sole cellular iron exporter (Nemeth et al., 2004, 4696 citations). Dysregulation causes iron overload disorders like hemochromatosis or anemia of inflammation (Ganz, 2013, 1072 citations). Over 10 key papers from 2004-2022 detail binding kinetics, mutations, and therapeutic targeting.
Why It Matters
The axis directly governs intestinal absorption, macrophage recycling, and hepatic release of iron into plasma, making it central to treating hereditary hemochromatosis and iron-loading anemias (Ganz, 2013). In cancer, disrupted ferroportin promotes tumor iron uptake and growth (Torti and Torti, 2013, 1579 citations). Therapeutic hepcidin mimics are in trials for transfusion-dependent anemias, while ferroportin inhibitors address dysmetabolic hyperferritinemia (Makker et al., 2015, 1354 citations). Clinical guidelines emphasize genetic testing for C282Y mutations in hepcidin-resistant ferroportin (Bacon et al., 2011, 702 citations).
Key Research Challenges
Quantifying Hepcidin Levels
Serum hepcidin measurement requires sensitive immunoassays due to its 5-95% concentration range in healthy volunteers (Ganz et al., 2008, 688 citations). Mass spectrometry validation remains inconsistent across labs. Standardization is needed for clinical diagnosis of iron disorders.
Ferroportin Mutation Effects
Mutations like C282Y cause hepcidin resistance leading to iron overload without elevated hepcidin (Bacon et al., 2011, 702 citations). Binding affinity and internalization kinetics vary by variant. Predicting clinical phenotypes from genotypes challenges therapy design.
Inflammatory Feedback Loops
Inflammation suppresses ferroportin via hepcidin, causing hypoferremia and anemia (Nemeth et al., 2004). Distinguishing primary overload from secondary inflammation markers like ferritin is difficult (Kell and Pretorius, 2014, 660 citations). Therapeutic mimics must avoid over-suppression.
Essential Papers
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Elizabeta Nemeth, Marie S. Tuttle, Julie Powelson et al. · 2004 · Science · 4.7K citations
Hepcidin is a peptide hormone secreted by the liver in response to iron loading and inflammation. Decreased hepcidin leads to tissue iron overload, whereas hepcidin overproduction leads to hypoferr...
Iron and cancer: more ore to be mined
Suzy V. Torti, Frank M. Torti · 2013 · Nature reviews. Cancer · 1.6K citations
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Jasbir Makker, Ahmad Hanif, Bharat Bajantri et al. · 2015 · Case Reports in Gastroenterology · 1.4K citations
Disturbances in iron metabolism can be genetic or acquired and accordingly manifest as primary or secondary iron overload state. Organ damage may result from iron overload and manifest clinically a...
Systemic Iron Homeostasis
Tomas Ganz · 2013 · Physiological Reviews · 1.1K citations
The iron hormone hepcidin and its receptor and cellular iron exporter ferroportin control the major fluxes of iron into blood plasma: intestinal iron absorption, the delivery of recycled iron from ...
Regulation of cellular iron metabolism
Jian Wang, Kostas Pantopoulos · 2011 · Biochemical Journal · 941 citations
Iron is an essential but potentially hazardous biometal. Mammalian cells require sufficient amounts of iron to satisfy metabolic needs or to accomplish specialized functions. Iron is delivered to t...
The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease
Xuexian Fang, Hossein Ardehali, Junxia Min et al. · 2022 · Nature Reviews Cardiology · 926 citations
Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Bruce R. Bacon, Paul C. Adams, Kris V. Kowdley et al. · 2011 · Hepatology · 702 citations
AASLD, American Association for the Study of Liver Diseases; ALD, alcoholic liver disease; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMP6, bone morphogenetic protein-6; C282Y,...
Reading Guide
Foundational Papers
Start with Nemeth et al. (2004, 4696 citations) for core binding/internalization mechanism; follow with Ganz (2013, 1072 citations) for systemic fluxes; then Wang and Pantopoulos (2011, 941 citations) for cellular regulation.
Recent Advances
Fang et al. (2022, 926 citations) on ferroptosis in cardiology; Makker et al. (2015, 1354 citations) on dysmetabolic hyperferritinemia.
Core Methods
Hepcidin ELISA (Ganz et al., 2008); ferroportin ubiquitination assays (Nemeth et al., 2004); genetic screening for C282Y (Bacon et al., 2011).
How PapersFlow Helps You Research Hepcidin-Ferroportin Axis
Discover & Search
Research Agent uses citationGraph on Nemeth et al. (2004) to map 4696 citing papers, revealing ferroportin internalization pathways; exaSearch queries 'hepcidin ferroportin mutations kinetics' to find 50+ recent therapeutics papers; findSimilarPapers expands from Ganz (2013) to related homeostasis reviews.
Analyze & Verify
Analysis Agent runs readPaperContent on Nemeth et al. (2004) to extract binding kinetics data, then verifyResponse with CoVe against Ganz (2013) for consistency; runPythonAnalysis plots hepcidin concentration distributions from Ganz et al. (2008) using pandas for GRADE B evidence grading on assay reliability.
Synthesize & Write
Synthesis Agent detects gaps in mutation-specific therapies from Bacon et al. (2011) and flags contradictions between Torti (2013) cancer links and Wang (2011) metabolism; Writing Agent uses latexEditText to draft axis diagrams, latexSyncCitations for 10-paper bibliography, and latexCompile for publication-ready review.
Use Cases
"Plot hepcidin-ferroportin binding affinity from Nemeth 2004 data"
Research Agent → searchPapers 'Nemeth 2004' → Analysis Agent → readPaperContent → runPythonAnalysis (NumPy/matplotlib Kd curve plot) → researcher gets publication-ready affinity graph with GRADE verification.
"Write LaTeX review on hepcidin therapeutics for hemochromatosis"
Synthesis Agent → gap detection (Bacon 2011 gaps) → Writing Agent → latexEditText (axis model) → latexSyncCitations (Ganz 2013 et al.) → latexCompile → researcher gets compiled PDF with synced references and mermaid feedback loop diagram.
"Find code for ferroportin internalization simulations"
Research Agent → searchPapers 'ferroportin kinetics model' → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets Python simulation code linked to Nemeth 2004, verified via runPythonAnalysis.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'hepcidin ferroportin axis', structures report with citationGraph centrality on Nemeth (2004), and exports mermaid regulatory loops. DeepScan applies 7-step CoVe to verify mutation impacts from Bacon (2011) against Ganz (2013). Theorizer generates hypotheses on mini-hepcidin designs from immunoassay data (Ganz et al., 2008).
Frequently Asked Questions
What defines the Hepcidin-Ferroportin Axis?
Hepcidin binds ferroportin, inducing lysosomal degradation and blocking iron export from cells (Nemeth et al., 2004).
What are key methods for studying the axis?
Serum immunoassays quantify hepcidin (Ganz et al., 2008); cell models assay ferroportin internalization kinetics (Nemeth et al., 2004).
What are seminal papers?
Nemeth et al. (2004, 4696 citations) discovered binding mechanism; Ganz (2013, 1072 citations) reviewed homeostasis.
What open problems exist?
Standardizing hepcidin assays for clinics; predicting mutation phenotypes (Bacon et al., 2011); balancing anti-inflammatory therapies.
Research Iron Metabolism and Disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Hepcidin-Ferroportin Axis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Iron Metabolism and Disorders Research Guide